| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.086 | 0.05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.31 | 0.05 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.05 |